Home / Journals Advances in Biochemistry / Endocannabinoid Deficiency Disorders
Endocannabinoid Deficiency Disorders
Submission DeadlineJun. 10, 2020

Online submission system: http://www.sciencepublishinggroup.com/login

Lead Guest Editor
David A Dawson
Department of Psychology, Northcentral University, San Diego, California, USA
Guest Editors
  • Sang-Hyuck Park
    Institute of Cannabis Research, Colorado State University - Pueblo, Pueblo, USA
  • Jana Sharp
    Spectral Analytics Inc., New York, USA
  • Kyle Dijon Hill
    University of Medicine and Health Sciences, St. Kitts, USA
  • Stephanie Robinson
    Green Cross Cannabis Consulting, Melbourne, Australia
  • Christopher Pauli
    University of Colorado, Boulder, Colorado, USA
  • Susan Foster
    Biomolecular Sciences, Spectral Analytics Inc., New York, USA
Introduction
Deficiencies of endocannabinoids have been implicated in a range of illnesses. Autism, Parkinson’s Disease, Alzheimer’s disease, Crohn’s Disease, diabetes, migraines, fibromyalgia, post-partum depression, muscular dystrophy, multiple sclerosis, Polyneuropathy, Post Traumatic Stress Disorder, and sleep disorders have all been implicated in studies as being caused by deficiencies of various endocannabinoids. This Special Issue is designed to provide endocannabinoid researchers a forum to publish original work into this next frontier of medicine.
Aims and Scope:
  1. Endocannabinoids
  2. Receptors
  3. FAAH
  4. Phytocannabinoids
  5. Cannabinoids
  6. Nutraceuticals
Guidelines for Submission
Manuscripts should be formatted according to the guidelines for authors
(see: http://www.sciencepublishinggroup.com/journal/guideforauthors?journalid=110).

Please download the template to format your manuscript.

ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186